Current infection-control issues for smallpox disease and vaccinia vaccine

Journal of Laboratory and Clinical Medicine

Volumn 142, Issue 4, 2003, Pages 239-245

  Bennett, Mary Ellen ^a,b   LeDell, Kathleen ^a  

^a MINNESOTA DEPARTMENT OF HEALTH   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALLPOX VACCINE; VACCINIA VACCINE;

CLINICAL TRIAL; DISEASE TRANSMISSION; HAND WASHING; HUMAN; IMMUNE FUNCTION TEST; PATIENT CARE; REVIEW; SIDE EFFECT; SMALLPOX; SMALLPOX VIRUS; UNITED KINGDOM;

EID: 0344117982     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(03)00145-8     Document Type: Review

References (20)

1. Center for Infectious Disease Research and Policy. Smallpox: current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, treatment, and prophylaxis, www. umn.edu/cidrap. Accessed September 16, 2003.
2. Centers for Disease Control and Prevention. Vaccinia (smallpox) vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Morbid Mortal Wkly Rep 2001;50. Available at: www.cdc.gov/mmwr/ preview/ mmwrhtml/rr5010al.htm. Accessed June 15, 2002.
3. Garner JS and the Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996;17:53-80 and Am J Infect Control 1996;24:24-52. Available at: www.cdc.gov/ncidod/hip/ ISOLAT/Isolat.htm. Accessed June 12, 2003.
4. Garner JS and the Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996;17:53-80 and Am J Infect Control 1996;24:24-52. Available at: www.cdc.gov/ncidod/hip/ ISOLAT/Isolat.htm. Accessed June 12, 2003.
5. Minnesota Department of Health and Association for Professionals in Infection Control and Epidemiology, Minnesota Chapter. Personal protective equipment (PPE) for smallpox or viral hemorrhagic fever patient care. Available at: www.health.state. mn.us/divs/dpc/biot/slides.htm. Accessed October 31, 2002.
6. Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling P, et al. Smallpox as a biological weapon: medical and public health management (consensus statement). JAMA 1999; 281:2127-37. Available at: jama.ama-assn.org/issues/v281n22/ ffull/jst90000.html. Accessed October 25, 2002.
7. Use of smallpox (vaccinia) vaccine, June 2002. Draft supplemental recommendation of the Advisory Committee on Immunization Practices Available at: www.bt.cdc.gov/agent/smallpox/ vaccination/acip-guidelines.asp. Accessed October 13, 2002.
8. Centers for Disease Control and Prevention. Smallpox response plan and guidelines: version 3.0, Guide B. Vaccination Guidelines for state and local health agencies (September 23, 2002), Guide C. Isolation and Quarantine Guidelines (April 2, 2003), Guide F. Environmental Control of Smallpox Virus (March 20, 2003) Available at: www.bt.cdc.gov/agent/smallpox/response-plan.asp/ index.asp. Accessed June 12, 2003.
9. Rutala WA. APIC guideline for selection and use of disinfectants. Am J Infect Control 1996;24:313-42.
10. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep 2003;52:1-16. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/rr5207al. htm. Accessed June 12, 2003.
11. Centers for Disease and Prevention. Smallpox vaccination program status by state. June 6, 2003 Available at: www.cdc.gov/ od/oc/media/spvaccin.htm. Accessed June 12, 2003.
12. Notice to readers: supplemental recommendations on adverse events following smallpox vaccine in the pre-event vaccination program: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2003;52: 282-4. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/ mm5213a5.htm. Accessed September 16, 2003.
13. Centers for Disease Control and Prevention. Evaluation of takes and non-takes. Available at: www.bt.cdc.gov/agent/smallpox/ vaccination/takes-non- takes.asp. Accessed June 12, 2003.
14. Neff JM, Lane JM, Fulginiti VA, Henderson DA. Contact vaccinia - transmission of vaccinia from smallpox vaccination. JAMA 2002;288:1901-4.
15. Centers for Disease Control and Prevention. Smallpox vaccination adverse events report. Available at: www.cdc.gov/od/oc/ media/spadverse.htm or www.cdc.gov/od/oc/media/spvigr.htm. Accessed June 12, 2003.
16. Centers for Disease and Prevention. Vaccinia immune globulin release and vaccinia transmission to contacts in the civilian program. Available at: www.cdc.gov/od/oc/media/spvigr.htm. Accessed June 12, 2003.
17. Department of Defense. Smallpox vaccination program adverse event information. Available at: www.smallpox.army.mil/event/ default.asp. Accessed June 12, 2003.
18. Centers for Disease Control and Prevention. Questions and answers: smallpox vaccination program implementation, transmission of vaccine virus. Available at: www.bt.cdc.gov/agent/ smallpox/vaccination/vaccination-program-qa. asp?type=cat&cat =Smallpox+Vaccine&subCat1=Transmission+of+Vaccine+ Virus. Accessed June 12, 2003.
19. Office of Laboratory Security, Health Canada. Material safety data sheet - infectious substances, vaccinia virus. 2001. Available at: www.hc-sc.gc.ca/pphb-dgspsp/msds-ftss/msds160e. html. Accessed September 15, 2002.
20. Centers for Disease Control and Prevention. Smallpox vaccination and adverse events training module. Available at: www.bt. cdc.gov/training/ smallpoxvaccine/reactions/prevent.html. Accessed November 15, 2002.